TheStreet's Biotech Bible: A Compendium of Biotech Companies for Today's Investor
| Author | : | |
| Rating | : | 4.69 (512 Votes) |
| Asin | : | B0185WM44O |
| Format Type | : | |
| Number of Pages | : | 154 Pages |
| Publish Date | : | 2014-06-11 |
| Language | : | English |
DESCRIPTION:
Heard there’s a lot going on in biotech but haven’t had time to look into it? Jim Cramer introduces this one-of-a-kind e-book with solid summaries of all the biotechnology and biopharmaceutical firms that have gone public in the past three years – their leaders, products, ongoing research, and financing. Researched by staff at The Street, TheStreet's Biotech Bible is designed to be a quick, useful source of information on today’s biotechnology industry.
Extensive Analysis of 186 Biotech Companies Wow!!! This is an amazing book for anyone serious about investing or considering investing in Biotech Stocks.Download a Kindle sample to review a decent amount of pages detailing analysis of some of the 186 Biotech Companies covered, starting with the letter "a" up to the point of ARDX; snapshot details of IPO date, Number of Shares issued, Partnerships, Board of Directors Bloodline details, Pipeline, Focus & Catalysts. Status of test Phase progress & Phase approval timelines.In 7 bullet points of the Introduction, Jim Cramer. One Star Is that a misprint? 200 bucks?